Guided Therapeutics, Inc.
GTHP
$0.20
-$0.03-12.28%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 58.95% | -64.15% | 8.28% | -89.46% | 34.51% |
| Total Depreciation and Amortization | -14.29% | 3.70% | 0.00% | 8.00% | 4.17% |
| Total Amortization of Deferred Charges | -12.73% | 1.85% | -20.59% | 1.49% | 76.32% |
| Total Other Non-Cash Items | -122.13% | 128.75% | -41.18% | 2,820.00% | 41.18% |
| Change in Net Operating Assets | -122.59% | 113.39% | -17.95% | 1,850.00% | -94.91% |
| Cash from Operations | -112.03% | -5.05% | -63.91% | 48.94% | 0.30% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | 50.40% | 98.41% | -82.25% | -- | -- |
| Total Debt Repaid | -10.15% | -57.60% | -76.06% | 51.70% | 29.67% |
| Issuance of Common Stock | 219.22% | 18.08% | -- | -- | -61.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -187.50% | 288.24% | 62.22% | -- | -- |
| Cash from Financing | 245.69% | 47.51% | -24.27% | 312.07% | -88.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,375.00% | 75.51% | -240.00% | 125.64% | -240.72% |